| HOME >> BIOLOGY >> TECHNOLOGY |
For most of us, gold is only valuable if we possess it in large-sized pieces. However, the "bigger is better" rule isn't the case for those interested in exploiting gold's exceptional ability to catalyze a wide variety of chemical reactions, including the oxidation of poisonous carbon monoxide (CO) into harmless carbon dioxide at room temperatures. That process, if industrialized, could potentially improve the effectiveness of catalytic converters that clean automobile exhaust and breathing devices that protect miners and firefighters. For this purpose, nanoclustersgold atoms bound together in crystals smaller than a strand of DNAare the size most treasured.
Using a pair of scanning transmission electron microscopy (STEM) instruments for which spherical aberration (a system fault yielding blurry images) is corrected, researchers at the National Institute of Standards and Technology (NIST), Lehigh University (Bethlehem, Pa.) and Cardiff University (Cardiff, Wales, United Kingdom) for the first time achieved state-of-the-art resolution of the active gold nanocrystals absorbed onto iron oxide surfaces. In fact, the resolution was sensitive enough to even visualize individual gold atoms.
The work is reported in the Sept. 5, 2008, issue of Science.
Surface science studies have suggested that there is a critical size range at which gold nanocrystals supported by iron oxide become highly active as catalysts for CO oxidation. However, the theory is based on research using idealized catalyst models made of gold absorbed on titanium oxide. The NIST/Lehigh/Cardiff aberration-corrected STEM imaging technique allows the researchers to study the real iron oxide catalyst systems as synthesized, identify all of the gold structures present in each sample, and then characterize which cluster sizes are most active in CO conversion.
The research team discovered that size matters a lotsamples ranged from those with little or no catalytic
'/>"/>
| Contact: Michael E. Newman michael.newman@nist.gov 301-975-3025 National Institute of Standards and Technology (NIST) Source:Eurekalert |
Related biology technology :
1. Medarex to Present at the Thomas Weisel Partners Healthcare Conference
2. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
3. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
4. Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Conference 2008
5. Thermage, Inc. to Present at the 2008 Thomas Weisel Partners Healthcare Conference
6. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
7. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
8. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
9. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
10. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
11. Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation
 |
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |